These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30944201)

  • 21. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
    Kun-Peng Z; Chun-Lin Z; Xiao-Long M
    Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
    Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
    Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Biochem Biophys Res Commun; 2019 Apr; 511(3):510-517. PubMed ID: 30819403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma.
    Teng J; Guo X; Wang H
    J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Long Noncoding RNA LOXL1-AS1 Promotes the Proliferation, Migration, and Invasion in Hepatocellular Carcinoma.
    Liu J; Zhai C; Liu D; Liu J
    Anal Cell Pathol (Amst); 2020; 2020():4182092. PubMed ID: 33381389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion.
    Zha Z; Han Q; Liu W; Huo S
    J Orthop Surg Res; 2020 Feb; 15(1):38. PubMed ID: 32013985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
    Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504.
    Wu X; Yan L; Liu Y; Shang L
    Aging (Albany NY); 2020 Dec; 13(1):219-227. PubMed ID: 33401251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
    Liao S; Zhou S; Wang C
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G; Song R; Wang L; Wu X
    Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
    Qu G; Ma Z; Tong W; Yang J
    Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function.
    Mi Z; Dong Y; Wang Z; Ye P
    J Orthop Surg Res; 2021 Jul; 16(1):470. PubMed ID: 34321018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA
    Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
    Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.